Transplantation of a Liver Allograft From a Hepatitis C Virus Seropositive Donor With Previous Sustained Virologic Response to an Uninfected Recipient Suffering Steroid Refractory Acute Graft Rejection With No Evidence of HCV Transmission

Transplantation of a Liver Allograft From a Hepatitis C Virus Seropositive Donor With Previous Sustained Virologic Response to an Uninfected Recipient Suffering Steroid Refractory Acute Graft Rejection With No Evidence of HCV Transmission

Background. The goal of treating chronic hepatitis C virus (HCV) infection is sustained virologic response (SVR). There is concern that despite achieving SVR, replication-competent HCV may be sequestered at low levels within the liver and could theoretically reactivate with immunosuppression. We rep...

Full description

Bibliographic Details
Main Authors: Robert A. Mitchell, MD, Trana Hussaini, PharmD, Alan H. Yau, MD, Mel Krajden, MD, Alissa J. Wright, MD, Charles H. Scudamore, MD, Vladimir Marquez Azalgara, MDCM, Siegfried R. Erb, MD, Eric M. Yoshida, MD
Format: Article
Language:English
Published: Wolters Kluwer 2018-03-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000763

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000763

Similar Items